During the past decade, Centre Odeon; Exploration Ophtalmologique conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Odeon; Exploration Ophtalmologique" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Centre Hospitalier Intercommunal Creteil" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "IVERIC bio, Inc." with 1 trials sponsored and "Oxurion" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Odeon; Exploration Ophtalmologique" #1 collaborator was "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre Odeon; Exploration Ophtalmologique" are "Geographic Atrophy" (5 trials), "Diabetes Mellitus" (1 trials), "Diabetic Macular Edema" (1 trials), "Diabetic Retinopathy" (1 trials) and "Exudative Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Centre Odeon; Exploration Ophtalmologique" in a lesser frequency.

Most popular intervention types in "Centre Odeon; Exploration Ophtalmologique" are "Drug" (8 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (3 trials), "Aflibercept" (2 trials), "Faricimab" (2 trials), "Lampalizumab" (2 trials) and "Sham" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Odeon; Exploration Ophtalmologique" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Centre Odeon; Exploration Ophtalmologique". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centre Odeon; Exploration Ophtalmologique, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Odeon; Exploration Ophtalmologique, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".